Brii Biosciences-B (02137.HK) granted a total of 7.258 million share options and a total of 1.3895 million restricted share units.

Zhito Finance APP News, Brii Biosciences-B (02137.HK) announced that on October 8, 2026, the Company granted a total of 7.258 million share options to 63 option grantees under the terms of the 2023 Share Option Scheme, subject to acceptance by the option grantees. As of the date of this announcement, the total number of issued shares was 722 million (excluding treasury shares). Upon full exercise of such share options granted under the Grant, the shares to be allotted and issued pursuant thereto represent approximately 1.0% of the total number of issued shares as of the date of this announcement (excluding treasury shares) and approximately 1.0% of the total number of issued shares as enlarged (excluding treasury shares and any vesting of restricted share units granted to restricted share unit grantees under the grant of restricted share units).